Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease
Journal of the American Heart Association · 19.08.2025 · 14 (16)
DOI: 10.1161/jaha.125.041564 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 19.08.2025. Verfasst von Jonghu Shin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Severance Cardiovascular Hospital Yonsei University College of Medicine Seoul Korea. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Angioplasty, Balloon, Peripheral Arterial Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The IVUS‐DCB (Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease) trial found that intravascular ultrasound (IVUS)–guided drug‐coated balloon (DCB) angioplasty was associated with superior 12‐month outcomes, compared with conventional angiography‐guided DCB angioplasty. However, the durability of these benefits remains uncertain. The aim of this study was to compare the 24‐month outcomes of IVUS‐guided versus angiography‐guided DCB angioplasty for femoropopliteal artery disease.
Methods
This extended study analyzed a total of 237 patients who were previously randomized into IVUS‐guidance (n=119) or angiography‐guidance (n=118) groups in the original IVUS‐DCB trial. The 24‐month clinical efficacy outcomes included freedom from clinically driven target lesion revascularization, sustained clinical and hemodynamic improvements, and freedom from major amputation.
Results
At 24‐month follow‐up, the IVUS‐guidance group exhibited significantly higher rates of freedom from clinically driven target lesion revascularization (87.4% versus 78.0%; hazard ratio, 0.46 [95% CI, 0.24–0.88]; P =0.02), sustained clinical improvement (82.4% versus 71.2%, P =0.02), and sustained hemodynamic improvement (74.8% versus 61.0%, P =0.01), compared with the angiography‐guidance group. No major amputations occurred in either group during the 24‐month follow‐up. There were no significant differences in safety outcomes between groups, including all‐cause death, cardiovascular death, and major bleeding.
Conclusions
At 24‐month follow‐up, IVUS‐guided DCB angioplasty for femoropopliteal artery disease continued to demonstrate superior outcomes, compared with angiography‐guided DCB angioplasty, in terms of freedom from clinically driven target lesion revascularization, sustained clinical improvement, and sustained hemodynamic improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Severance Cardiovascular Hospital Yonsei University College of Medicine Seoul Korea.
- Division of Cardiology Hanil General Hospital Seoul Korea.
- Division of Cardiology, Cardiovascular Center Bucheon Sejong Hospital Bucheon Korea.
- National Health Insurance Service Ilsan Hospital Goyang Korea.
- Division of Cardiology Chungnam National University Sejong Hospital Sejong Korea.
- Division of Cardiology Chungnam National University Hospital Daejeon Korea.
ORCID-Profile: Chul-Min Ahn, Seung-Jun Lee, Sang-Hyup Lee, Yong-Joon Lee, Byeong-Keuk Kim, Myeong-Ki Hong, Yangsoo Jang, Tae-Hoon Kim, Ha-Wook Park, Ji Yong Jang, Jae-Hwan Lee, Su Hong Kim, Eui Im, Donghoon Choi, Young-Guk Ko
Zitieren
APA
Shin, J., Ahn, C. M., Lee, S. J., Lee, S. H., Lee, Y. J., Kim, B. K., Hong, M. K., Jang, Y., Kim, T. H., Park, H. W., Jang, J. Y., Lee, J. H., Park, J. H., Kim, S. H., Im, E., Park, S. H., Choi, D., Ko, Y. G., & IVUS‐DCB investigators (2025). Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease. Journal of the American Heart Association, 14(16). https://doi.org/10.1161/jaha.125.041564
Vancouver
Shin J, Ahn CM, Lee SJ, Lee SH, Lee YJ, Kim BK, et al. Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease. Journal of the American Heart Association. 2025;14(16). doi:10.1161/jaha.125.041564
BibTeX
@article{Shin2025,
author = {Shin, Jonghu and Ahn, Chul-Min and Lee, Seung-Jun and Lee, Sang-Hyup and Lee, Yong-Joon and Kim, Byeong-Keuk and Hong, Myeong-Ki and Jang, Yangsoo and Kim, Tae-Hoon and Park, Ha-Wook and Jang, Ji Yong and Lee, Jae-Hwan and Park, Jae-Hyeong and Kim, Su Hong and Im, Eui and Park, Sang-Ho and Choi, Donghoon and Ko, Young-Guk and IVUS‐DCB investigators, IVUS‐DCB investigators},
title = {Twenty‐Four–Month Outcomes of Intravascular Ultrasound‐Guided Drug‐Coated Balloon Angioplasty for Femoropopliteal Artery Disease},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {16},
doi = {10.1161/jaha.125.041564}
}
EUVIMED